14.90
+0.68%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About NatureWise Biotech & Medicals
Its shares trade on Taipei Exchange under the ticker 4732.TWO. It has been listed since 25 December 2007. In the fiscal year to 31 December 2025, it reported revenue of TWD 176.8m and a net loss of TWD 92.3m. At that date it held total assets of TWD 712.9m and shareholders' equity of TWD 624.3m.
NatureWise Biotech & Medicals Corp. engages in the wholesale and retail of Chinese and Western medicines and medical equipment. The company is headquartered in Taipei City, Taipei. The company went IPO on 2007-12-25. The firm's products mainly include medicines and healthcare products. The firm's products are mainly applied to reduce hypercholesterolemia and regulate physiological function and physical fitness. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 25 Dec 2007
- Employees
- 15
- Website
- naturewise.com.tw ↗
Leadership
Pay as last reported
- Mr. Zhongyang HuangChairman of the Board, Acting General Manager, since 2000TWD 188,000
- Wande WuVice Chairman of the Board, since 2013
- Xiaojing HeDeputy General Manager
- Jiazhen HouDeputy General Manager-Pharmaceutical R&D
- Xinhuang LinDeputy General Manager-BusinessTWD 971,000
- Xiujuan DengAssistant General Manager-Finance and Accounting & Administration and Management
- Jingjing WuHead of Finance and Accounting
- Minhua HuaDirector
- Junyao LinDirector
- Mr. Ching-Yang SuDirector
- Fenglin XuDirector
- An-Rong LeeIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- NatureWise Biotech & Medicals Corp. distributes medicines for hypercholesterolemia in Taipei City market.
- The company's healthcare products regulate physiological functions and physical fitness effectively.
- NatureWise Biotech & Medicals Corp. operates with 15 employees in Consumer Staples sector.
Weaknesses
- The company has limited overseas market presence beyond domestic distribution.
- NatureWise Biotech & Medicals Corp. lacks expansion into new product segments.
- 15 employees restrict scalability in Consumer Staples industry.
Opportunities
- NatureWise Biotech & Medicals Corp. can expand into overseas markets for healthcare products.
- The firm's focus on hypercholesterolemia products offers growth in health-conscious markets.
- Increasing demand for physiological regulation products in Taipei City presents opportunity.
Threats
- Competition from domestic pharmaceutical firms in Taipei City market.
- NatureWise Biotech & Medicals Corp. faces limited product diversification threats.
- Overseas market entry barriers challenge expansion efforts.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.